Background: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer that grows rapidly, can metastasize, and is capable of adapting to different metabolic conditions. However, the effect of TNBC on the insulin-producing islets of Langerhans in the pancreas is not yet fully understood. In this study, amino acids and associated metabolites in pancreatic islets were examined using an experimental TNBC model. Methods: The study utilized 10 female BALB/c mice aged 8–12 weeks. The animals were divided into two groups (n=5): a control group and a TNBC group. A suspension containing 1×10⁶ viable 4T1 cells in 100 µL was then prepared and injected subcutaneously into the mammary region of the mice. Tumor growth was measured every two days using calipers. At the end of the experiment, pancreatic islets were isolated using collagenase administered via the bile duct, and metabolites were analyzed by LC-MS/MS. Results: In the TNBC group, levels of histidine, ornithine, proline, anserine, cystathionine, serotonin, histamine, and ethanolamine increased; levels of isoleucine, serine, and threonine decreased. All these changes were found to be statistically significant (p<0.05). After FDR correction, threonine, isoleucine, serine, and anserine retained their significance. The first two principal components explained 42.3% and 23% of the total variation, respectively. The metabolites that contributed most to the differentiation of the groups were threonine, isoleucine, serine, proline, and histidine. Conclusion: These findings suggest that TNBC may alter amino acid metabolism in pancreatic islets. However, further studies are needed to understand the effects of these changes on pancreatic function and insulin secretion.